BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30791637)

  • 1. Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis.
    Correale J; Marrodan M; Ysrraelit MC
    Biomedicines; 2019 Feb; 7(1):. PubMed ID: 30791637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central role of mitochondria in axonal degeneration in multiple sclerosis.
    Campbell GR; Worrall JT; Mahad DJ
    Mult Scler; 2014 Dec; 20(14):1806-13. PubMed ID: 25122475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
    Simkins TJ; Duncan GJ; Bourdette D
    Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis.
    López-Muguruza E; Matute C
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE; Nichols PP; Bates D; Turnbull DM
    Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis.
    Kennedy PGE; George W; Yu X
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons.
    Duncan GJ; Simkins TJ; Emery B
    Front Cell Dev Biol; 2021; 9():653101. PubMed ID: 33763430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v10-5. PubMed ID: 16254696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
    Madsen PM; Pinto M; Patel S; McCarthy S; Gao H; Taherian M; Karmally S; Pereira CV; Dvoriantchikova G; Ivanov D; Tanaka KF; Moraes CT; Brambilla R
    J Neurosci; 2017 Oct; 37(42):10185-10199. PubMed ID: 28931570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
    Huizinga R; Gerritsen W; Heijmans N; Amor S
    Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Astrocytes in Multiple Sclerosis Progression.
    Correale J; Farez MF
    Front Neurol; 2015; 6():180. PubMed ID: 26347709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights in pathogenesis of multiple sclerosis: nitric oxide may induce mitochondrial dysfunction of oligodendrocytes.
    Lan M; Tang X; Zhang J; Yao Z
    Rev Neurosci; 2018 Jan; 29(1):39-53. PubMed ID: 28822986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G; Trapp B; Dutta R
    Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis.
    Sedel F; Bernard D; Mock DM; Tourbah A
    Neuropharmacology; 2016 Nov; 110(Pt B):644-653. PubMed ID: 26327679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination.
    Tsunoda I; Fujinami RS
    Springer Semin Immunopathol; 2002; 24(2):105-25. PubMed ID: 12503060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.